4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Jiliang Zhou. An emerging role for Hippo-YAP signaling in cardiovascular development[J]. The Journal of Biomedical Research, 2014, 28(4): 251-254. DOI: 10.7555/JBR.28.20140020
Citation: Jiliang Zhou. An emerging role for Hippo-YAP signaling in cardiovascular development[J]. The Journal of Biomedical Research, 2014, 28(4): 251-254. DOI: 10.7555/JBR.28.20140020

An emerging role for Hippo-YAP signaling in cardiovascular development

Funds: 

This study was supported by a grant (No. R01HL109605) from the National Heart, Lung, and Blood Institute, NIH.

More Information
  • Received Date: February 03, 2014
  • The Hippo signaling pathway was originally discovered in Drosophila and shown to be critical for organ size control and tumorigenesis. This pathway consists of a cascade of kinases and several adaptors that lead to the phosphorylation and inhibition, through nuclear exclusion, of the transcriptional cofactor Yorkie in Drosophila or YAP (yes associated protein) in mammals. Recent studies demonstrate that cardiac-specific deletion of the Hippo pathway kinase Mst (STE20-like protein kinases) co-activator WW45 (WW domain-containing adaptor 45), Mst1, Mst2, or Lats2 (large tumor suppressor homologue 2) in mice result in over-grown hearts with elevated cardiomyocyte proliferation. Consistent with these observations, over-expression of YAP in the mouse embryonic heart increases heart size and promotes cardiac regeneration and contractility after myocardial infarction by inducing cardiomyocyte proliferation, whereas deletion of YAP in the mouse heart impedes cardiomyocyte proliferation, causing myocardial hypoplasia and embryonic or premature lethality. YAP has also been shown to play an important role in the vascular system. Specific-deletion of YAP from vascular smooth muscle cells in mice results in aberrant development of large arteries with a hypoplastic arterial wall phenotype. Hippo-YAP signaling cross-talks with other signaling pathways such as IGF (insulin-like growth factor) and Wnt signaling to promote heart growth by increasing expression of cell cycle genes. The purpose of this review is to summarize these recent findings and discuss potential diagnostic or therapeutic strategies in cardiovascular system based on manipulating the Hippo-YAP signaling.
  • Related Articles

    [1]Yuetong Chen, Chen Li, Yi Shi, Jiali Dai, Yixuan Meng, Shuwei Li, Cuiju Tang, Dongying Gu, Jinfei Chen. Identification of common genetic variants in KCNQ family genes associated with gastric cancer survival in a Chinese population[J]. The Journal of Biomedical Research, 2025, 39(1): 76-86. DOI: 10.7555/JBR.38.20240040
    [2]Yujuan Zhang, Kai Lu, Xu Wu, Hanting Liu, Junyi Xin, Xiaowei Wang, Weida Gong, Qinghong Zhao, Meilin Wang, Haiyan Chu, Mulong Du, Guoquan Tao, Zhengdong Zhang. Genetic variants in the Hedgehog signaling pathway genes are associated with gastric cancer risk in a Chinese Han population[J]. The Journal of Biomedical Research, 2022, 36(1): 22-31. DOI: 10.7555/JBR.35.20210091
    [3]Qiu Jinchun, Guo Hongli, Li Ling, Xu Zeyue, Xu Zejun, Jing Xia, Hu Yahui, Wen Xiaoyi, Chen Feng, Lu Xiaopeng. Valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy— a pilot longitudinal study[J]. The Journal of Biomedical Research, 2021, 35(1): 61-67. DOI: 10.7555/JBR.34.20200057
    [4]Ma Hongxia, Shen Hongbing. From human genome epidemiology to systems epidemiology: current progress and future perspective[J]. The Journal of Biomedical Research, 2020, 34(5): 323-327. DOI: 10.7555/JBR.34.20200027
    [5]Naureen Javeed, Debabrata Mukhopadhyay. Exosomes and their role in the micro-/macro-environment: a comprehensive review[J]. The Journal of Biomedical Research, 2017, 31(5): 386-394. DOI: 10.7555/JBR.30.20150162
    [6]So-Hye Hong, Jae-Eon Lee, Hong Sung Kim, Young-Jin Jung, DaeYoun Hwang, Jae Ho Lee, Seung Yun Yang, Seung-Chul Kim, Seong-Keun Cho, Beum-Soo An. Effect of vitamin D3 on production of progesterone in porcine granulosa cells by regulation of steroidogenic enzymes[J]. The Journal of Biomedical Research, 2016, 30(3): 203-208. DOI: 10.7555/JBR.30.2016K0012
    [7]Rezvan Hashemi, Sakineh Shab Bidar, Moloud Payab, Ramin Heshmat, Ahmad Reza Dorosti-Motlagh. Urgent need of vitamin D supplementation among Iranian elderly: a cross-sectional study[J]. The Journal of Biomedical Research, 2014, 28(6): 509-512. DOI: 10.7555/JBR.28.20140089
    [8]Nuan Wang, Xianming Chen, Deqin Geng, Hongli Huang, Hao Zhou. Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia[J]. The Journal of Biomedical Research, 2013, 27(1): 29-36. DOI: 10.7555/JBR.27.20120047
    [9]Min Zhang, Yan Zhang, Shuaishuai Zhu, Xiaoyu Li, Qing Yang, Hui Bai, Qi Chen. Genetic variants of the class A scavenger receptor gene are associated with coronary artery disease in Chinese[J]. The Journal of Biomedical Research, 2012, 26(6): 418-424. DOI: 10.7555/JBR.26.20110116
    [10]Hua Huang, Juan Wu, Guangfu Jin, Hanze Zhang, Yanbing Ding, Zhaolai Hua, Yan Zhou, Yan Xue, Yan Lu, Zhibin Hu, Yaochu Xu, Hongbing Shen. A 5'-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population[J]. The Journal of Biomedical Research, 2010, 24(2): 100-106.
  • Cited by

    Periodical cited type(27)

    1. Boda VK, Yasmen N, Jiang J, et al. Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel. Med Res Rev, 2024, 44(6): 2510-2544. DOI:10.1002/med.22048
    2. Agrawal K, Asthana S, Kumar D. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers (Basel), 2023, 15(20): 4920. DOI:10.3390/cancers15204920
    3. Zhou Y, Pereira G, Tang Y, et al. 3D Porous Scaffold-Based High-Throughput Platform for Cancer Drug Screening. Pharmaceutics, 2023, 15(6): 1691. DOI:10.3390/pharmaceutics15061691
    4. Safa AR. Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces. Cancer Drug Resist, 2022, 5(4): 850-872. DOI:10.20517/cdr.2022.20
    5. Gal O, Betzer O, Rousso-Noori L, et al. Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy. J Nanotheranostics, 2022, 3(4): 177-188. DOI:10.3390/jnt3040012
    6. Scioli MG, Terriaca S, Fiorelli E, et al. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. Int J Mol Sci, 2021, 22(19): 10572. DOI:10.3390/ijms221910572
    7. Keyvani-Ghamsari S, Khorsandi K, Rasul A, et al. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenetics, 2021, 13(1): 120. DOI:10.1186/s13148-021-01107-4
    8. Safa AR. Resistance to drugs and cell death in cancer stem cells (CSCs). J Transl Sci, 2020, 6(3): 341. DOI:10.15761/jts.1000341
    9. Chandimali N, Koh H, Kim J, et al. BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer. Oncol Lett, 2020, 20(4): 103. DOI:10.3892/ol.2020.11964
    10. Mukherjee S. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples. Sci Rep, 2020, 10(1): 10937. DOI:10.1038/s41598-020-67753-5
    11. Zhou JJ, Xiao Y, Li H, et al. Overexpression of Malic Enzyme 2 Indicates Pathological and Clinical Significance in Oral Squamous Cell Carcinoma. Int J Med Sci, 2020, 17(6): 799-806. DOI:10.7150/ijms.43832
    12. Sun Z, Wang L, Zhou Y, et al. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein. Cell Mol Neurobiol, 2020, 40(5): 767-784. DOI:10.1007/s10571-019-00771-8
    13. Zhang Q, Xu B, Chen J, et al. Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival. J Clin Lab Anal, 2020, 34(3): e23082. DOI:10.1002/jcla.23082
    14. Megías J, Martínez A, San-Miguel T, et al. Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide. Invest New Drugs, 2020, 38(2): 299-310. DOI:10.1007/s10637-019-00788-2
    15. Li Z, Chen Y, An T, et al. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway. J Exp Clin Cancer Res, 2019, 38(1): 139. DOI:10.1186/s13046-019-1134-y
    16. Ghosh D, Nandi S, Bhattacharjee S. Combination therapy to checkmate Glioblastoma: clinical challenges and advances. Clin Transl Med, 2018, 7(1): 33. DOI:10.1186/s40169-018-0211-8
    17. Grande S, Palma A, Ricci-Vitiani L, et al. Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs. Stem Cells Int, 2018, 2018: 3292704. DOI:10.1155/2018/3292704
    18. Zuccarini M, Giuliani P, Ziberi S, et al. The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor. Genes (Basel), 2018, 9(2): 105. DOI:10.3390/genes9020105
    19. Bhere D, Tamura K, Wakimoto H, et al. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis. Neuro Oncol, 2018, 20(2): 215-224. DOI:10.1093/neuonc/nox138
    20. Lee S, Kwon MC, Jang JP, et al. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Int J Oncol, 2017, 51(2): 414-424. DOI:10.3892/ijo.2017.4054
    21. Jovčevska I, Zupanec N, Urlep Ž, et al. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. Oncotarget, 2017, 8(27): 44141-44158. DOI:10.18632/oncotarget.17390
    22. Hiramatsu H, Kobayashi K, Kobayashi K, et al. The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells. Sci Rep, 2017, 7(1): 889. DOI:10.1038/s41598-017-00982-3
    23. Zheng X, Pang B, Gu G, et al. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis. Int J Biol Sci, 2017, 13(2): 245-253. DOI:10.7150/ijbs.16818
    24. Bijangi-Vishehsaraei K, Reza Saadatzadeh M, Wang H, et al. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. J Neurosurg, 2017, 127(6): 1219-1230. DOI:10.3171/2016.8.JNS161197
    25. Majewska E, Szeliga M. AKT/GSK3β Signaling in Glioblastoma. Neurochem Res, 2017, 42(3): 918-924. DOI:10.1007/s11064-016-2044-4
    26. Kanabur P, Guo S, Simonds GR, et al. Patient-derived glioblastoma stem cells respond differentially to targeted therapies. Oncotarget, 2016, 7(52): 86406-86419. DOI:10.18632/oncotarget.13415
    27. Wang K, Kievit FM, Erickson AE, et al. Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells. Adv Healthc Mater, 2016, 5(24): 3173-3181. DOI:10.1002/adhm.201600684

    Other cited types(0)

Catalog

    Article Metrics

    Article views (4092) PDF downloads (1111) Cited by(27)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return